Acadia Pharmaceuticals | Costo Del Venduto





Costo Del Venduto Cambiamento Data
Acadia Pharmaceuticals USD 21.65M 913K 2025-09
ALKERMES USD 51.59M 2.13M 2025-09
Alnylam Pharmaceuticals USD 267.72M 67.57M 2025-12
Biogen USD 810.1M 205.1M 2025-09
BioMarin Pharmaceutical USD 144.93M 10M 2025-09
Bristol-Myers Squibb USD 4.92B 657M 2025-12
Cara Therapeutics USD 0 0 2025-03
Corcept Therapeutics USD 4.6M 1.16M 2025-09
Cytokinetics USD 112.55M 12.71M 2025-06
Eisai JPY 51.08B 5.56B 2025-12
Eli Lilly USD 3.37B 363.7M 2025-12
Incyte USD 121.18M 22.18M 2025-12
J&J USD 7.97B 689M 2025-12
Moderna USD 452M 245M 2025-12
Neurocrine Biosciences USD 17.6M 246.4M 2025-12
Pfizer USD 6.29B 2.12B 2025-12
Prothena USD 28.94M 11.58M 2025-09
PTC Therapeutics USD 23.32M 7.83M 2025-09
Sarepta Therapeutics USD 151.45M 1.77M 2025-09
Ultragenyx Pharmaceutical USD 29M 1.01M 2025-12
Vanda Pharmaceuticals USD 198.77M 151.12M 2024-12
Vertex Pharmaceuticals USD 466M 51.2M 2025-12


Acadia Pharmaceuticals Costo Del Venduto - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.